Industry positive over drive for reform in Italy
This article was originally published in Clinica
Italy is warming to the idea of establishing a health technology assessment system, which the medical device industry has long pressed for, as a key to improving the inefficiencies - and lack of accountability - of the national health service.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.